The treatment of tardive dyskinesia with baclofen
β Scribed by W. M. Glazer; D. C. Moore; M. B. Bowers; B. S. Bunney; M. Roffman
- Publisher
- Springer
- Year
- 1985
- Tongue
- English
- Weight
- 437 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Treatment of tardive dystonia with oral baclofen produces ambivalent and overall disappointing results. However, because only a small proportion of the baclofen penetrates into the central nervous system when administered orally, we tested whether it is possible to increase the efficacy
Six patients with severe and stable tardive dyskinesia were treated with verapamil, a calcium channel blocker, in doses ranging from 240 to 400 mg/day. Weekly assessments were made using the Simpson tardive dyskinesia rating scale. Neuroleptic medication was held constant during the 3-month baseline
Relationships between tardive dyskinesia (TD) and the life expectancy of schizophrenic patients who suffer it were examined in two studies over a 50-month period. In a prospective study, the mortality rate was found to be higher in patients with T D than in those without. This suggests either that T